On 11 September 2026, YEEBO (INT'L H) (00259.HK) announced that Suzhou Qingyue Optoelectronics Technology, formerly listed on the SSE STAR Market, has triggered a mandatory delisting scenario for trading-related reasons after its daily closing price fell below RMB 1 for 20 consecutive trading days, with trading suspended on the SSE from 11 September 2026 and delisting possible; Suzhou Qingyue must engage a qualified sponsoring broker to transfer its shares to the NEEQ or other venues so trading can resume within 45 trading days of formal delisting, while the group's investment carrying amount was approximately HKD 161,000,000 as at 31 March 2026, or 2.28% of total assets and 2.85% of total equity.
GENSCRIPT BIO (01548.HK) plans to issue in total 77.13 million shares by placement, with estimated net proceeds of HKD 2.33 billion.
On 11 September 2026, DMALL (02586.HK) announced that controlling shareholder Dr. Zhang Wenzhong bought 1,361,400 ordinary shares on the open market for the first time on 10 September through Celestial Limited with his own funds, saying the price does not reflect the company's intrinsic value, and he intends to increase his holding further at an appropriate time.
On 10 September 2026, GUOQUAN (02517.HK) announced the grant of 90,486,712 incentive shares to 126 employee participants under its 2026 H Share Incentive Scheme, vesting in four equal tranches and linked to core operating profit targets of no less than RMB 600 million to RMB 1 billion for 2026 to 2029.
On 11 September 2026, TENCENT MUSIC-SW (01698.HK) announced the completion of a USD 1 billion senior unsecured notes offering comprising USD 500 million of 5.050% notes due 2031 and USD 500 million of 5.650% notes due 2036, raising net proceeds of about USD 991.9 million for offshore debt refinancing, share repurchases and general corporate purposes, with listing on the Stock Exchange expected on 11 September.
On 11 September 2026, GENSCRIPT BIO (01548.HK) announced the placing of 77,126,000 new shares at HKD 30.50 each, a discount of about 4.7% to the previous close and about 3.38% of the enlarged share capital, with net proceeds of about HKD 2.33 billion, of which around 70% is earmarked for AIDD platform capacity and infrastructure.
On 10 September 2026, TYK MEDICINES-B (02410.HK) announced that Chairman Dr. Wu Yusheng bought 635,000 H shares on the open market for about HKD 2.09 million, or roughly 0.17% of the issued share capital, subject to a six-month voluntary lock-up; further purchases of up to HKD 3.0 million are anticipated.
On 10 September 2026, FEIYANG GROUP (01901.HK) announced that its wholly-owned subsidiary signed strategic cooperation agreements with DingTalk China and Hongxiong AI, becoming a priority service provider and ecosystem partner of DingTalk Qwen in tourism and building a tourism-specific memory bank on the MemoryBear engine; both are framework arrangements with no material impact expected on FY2026 results.
On 10 September 2026, ENVISION GREEN (01783.HK) announced that its wholly owned subsidiary Shanghai Youfu Cloud Computing proposes to acquire over 100 high-performance NVIDIA servers from Shanghai Shunquan Technology for RMB 380.0 million (approximately HKD 439.7 million), with the vendor ultimately controlled by Taiwan-listed Inventec. Aggregated with the August server purchase and the intelligent computing business acquisition, the transaction constitutes a very substantial acquisition requiring shareholder approval, with the circular to be despatched no later than 2 October.
On 11 September 2026, SH IND URBAN (00563.HK) clarified online media reports, stating that a possible listing of certain group assets, including a subsidised rental housing property portfolio, by way of a REIT remains at a preliminary and exploratory stage. The company is evaluating the structure and feasibility, including whether it would proceed via a REIT listing, direct disposal or alternative structure, and emphasized that the transaction may or may not proceed.
On 11 September 2026, Transwarp Technology (Shanghai) (06727.HK) published its global offering of 14,010,800 H shares, comprising 700,600 shares under the Hong Kong public offer and 13,310,200 under the international offering, at a maximum offer price of HKD 61.00 per share with an indicative range of HKD 49.00 to HKD 61.00. Pricing is expected on 17 September with trading to commence on the Stock Exchange on 21 September in board lots of 100 shares.
On 11 September 2026, GUOXIA TECH (02655.HK) announced a three-year strategic cooperation agreement with Siemens Ltd., China, covering 35kV and below smart power distribution equipment, digital hardware and software, the Xcelerator platform and integrated power supply and distribution solutions for AI computing centers.
On 11 September 2026, OCUMENSION-B (01477.HK) announced that the NDA for OT-301 (NCX 470, latanoprostene bunod) to lower IOP in open-angle glaucoma or ocular hypertension patients has been accepted by the NMPA's Center for Drug Evaluation.
On 10 September 2026, CHERVON (02285.HK) announced the appointment of Mr. Joseph Galli Jr. as CEO of the group with effect from the same date, with founder Mr. Pan Longquan ceasing to be CEO while remaining executive director and chairman; Mr. Galli previously served as CEO and executive director of Techtronic Industries (00669.HK) from February 2008 to May 2024, as director and CEO of Newell Rubbermaid from 2001 to 2005 and as director, president and COO of Amazon.com from 1999 to 2000, having spent more than 19 years at Black & Decker, and held no interests in the company's shares as at the announcement date.
On 10 September 2026, the SFC directed the Stock Exchange, under section 8(1) of the Securities and Futures (Stock Market Listing) Rules, to suspend trading in the shares of Cloudbreak Pharma (02592.HK) from 9:00 a.m. that day, citing serious concerns that its initial public offering may have been artificially manipulated to create a false appearance of demand for its shares and that suspension is necessary or appropriate pending the investigation to maintain an orderly and fair market and protect the investing public; the investigation is ongoing and the SFC will not comment further, with the company listed on the Main Board since 3 July 2025.
On 10 September 2026, TRADEGO (08017.HK) announced subscriptions and redemptions of the Bosera Money Market Fund between 8 February 2024 and 18 August 2026 for treasury management using internal resources, generating annualised returns of approximately 2.0% to 2.3%, with a peak outstanding value of HKD 75,559,893 on 8 October 2025 and a highest applicable percentage ratio of approximately 33.89%; the company confirmed the subscriptions constitute acquisitions of financial assets under Chapter 19 of the GEM Listing Rules, forming discloseable or major transactions, and has suspended subscriptions and adopted investment compliance guidelines and a tiered approval regime among other remedial actions, having received net investment returns of approximately HKD 962,010.
